NCT05586399

Brief Summary

The purpose of this study is to investigate the effect on maximal strength training on muscle function, lung function and quality of life for patients diagnosed with COPD grade II-III (Gold scale). Each patient will complete a total of 20 exercise session participating in a rehabilitation program for 4 weeks. Physiological and functional testing will be performed 4 weeks before the training intervention, at baseline and after the intervention period.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at P25-P50 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 19, 2022

Completed
27 days until next milestone

Study Start

First participant enrolled

November 15, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

October 19, 2022

Status Verified

September 1, 2022

Enrollment Period

1.6 years

First QC Date

September 6, 2022

Last Update Submit

October 17, 2022

Conditions

Keywords

Strength trainingLung functionQuality of life

Outcome Measures

Primary Outcomes (9)

  • Change in Maximal Strenght

    Measured in 1 repetition maximum (kg) in leg press.

    4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.

  • Change in Rate of Force Development

    Measured in Newton using a force plate

    4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.

  • Change in Forced Expiratory Volume (FEV1)

    Measured using spirometry as the maximal volume of air (liter) exhaled in the first second of expiration

    4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.

  • Change in Peak Expiratory Flow (PEF)

    Measured using spirometry as the maximal speed of expiration (Measured as liter/min)

    4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.

  • Change in Work Economy

    Measured using CPET walking on a treadmill at a standardized speed and incline (Measured as VO2 ml/kg/min)

    4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.

  • Change in Maximal Oxygen Consumption

    Measured using CPET in maximal test walking until exhaustion(Measured as VO2 ml/kg/min)

    4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.

  • Change in Stair Climbing-test

    Measured in seconds as the average of two attempts

    4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.

  • Change in Timed up and Go-test

    Measured in seconds as the average of two attempts

    4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.

  • Change in 6 Minutes Walk Test

    Measured in meters

    4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.

Secondary Outcomes (5)

  • Changes in health-related quality of life - Norwegian RAND36

    4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.

  • Changes in health-related quality of life - Hospital and Anxiety Score (HADS)

    4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.

  • Changes in health-related quality of life - International physical activity questionnaire (IPAQ)

    4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.

  • Changes in health-related quality of life - EQ-5D-5L

    4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.

  • Changes in health-related quality of life - Visual Analogue Scale (VAS)

    4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation.

Study Arms (1)

Exercise intervention

EXPERIMENTAL

Participants performing a rehabilitation program for 5 times a week in a total of 4 weeks in one of two rehabilitation centers in Trondheim, Norway. The aim is to perform a total of 20 maximal strength training interventions supervised by one or more health professionals. Maximal strength training will be performed with 4 repetitions and 4 series at 90-95% of one repetition maximum.

Behavioral: Maximal strength training in COPD

Interventions

Participate in a rehabilitation program for 4 weeks, with exercise 5 times a week. Supervised maximal strength training in a leg press machine for a total of 20 exercise sessions. Patients will participate in rehabilitation in one of two rehabilitations centers in Trondheim, Norway.

Exercise intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • COPD-diagnosis grade II-III (Gold Classification)
  • Patients in one of two rehabilitation centres in Trondheim, Norway.
  • Must be able to perform the test procedures walking or running on a treadmill.
  • Must participate in at least 18 of the 20 planned training sessions.

You may not qualify if:

  • Other pulmonary disease than COPD
  • Diabetes mellitus or other metabolic diseases
  • Use of corticosteroids the last 6 weeks
  • Pulmonary infection the last 4 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

My Workout - Medical Rehabilitation Clinic

Trondheim, 7047, Norway

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jan Helgerud, PhD

    Norwegian University of Science and Technology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jan Helgerud, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Pre-test 4 weeks before the intervention period (Subjects functioning as their own control), tests at baseline and 4 weeks after the intervention period.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2022

First Posted

October 19, 2022

Study Start

November 15, 2022

Primary Completion

June 30, 2024

Study Completion

June 30, 2024

Last Updated

October 19, 2022

Record last verified: 2022-09

Locations